Francis B Maddalo

Francis B Maddalo is an experienced biotechnology and manufacturing operations professional, currently serving as Site Head and COO at HTL Biotechnology since April 2020, where responsibilities include day-to-day operations, P&L management, technology transfers, and GMP operations for a 30k square foot facility. Prior roles include SVP of Manufacturing Operations at Cytovance Biologics, where strategic and daily CMO operations were managed, and VP of Manufacturing/Operations at Perosphere Inc., focusing on the establishment of a new manufacturing site for novel drugs. Other significant positions held include VP of Operations at DSM Biologics, where high-density cell culture systems were developed, and VP of Manufacturing Operations at Verax, overseeing regulatory approvals for new medical products. Additionally, Francis B Maddalo has offered consulting services, notably at Hemcon, and has held senior manufacturing roles at TEI Biosciences Inc. and Collgenesis. Francis B Maddalo's educational background includes a Master of Science in Physiology/Virology from Northeastern University and a Bachelor of Science in Biology from UMass Boston.